These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29517810)

  • 1. Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
    Agarwal N; Pal SK; Hahn AW; Nussenzveig RH; Pond GR; Gupta SV; Wang J; Bilen MA; Naik G; Ghatalia P; Hoimes CJ; Gopalakrishnan D; Barata PC; Drakaki A; Faltas BM; Kiedrowski LA; Lanman RB; Nagy RJ; Vogelzang NJ; Boucher KM; Vaishampayan UN; Sonpavde G; Grivas P
    Cancer; 2018 May; 124(10):2115-2124. PubMed ID: 29517810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of Chinese patients with urothelial carcinoma.
    Yang B; Zhao X; Wan C; Ma X; Niu S; Guo A; Wang J; Wang J; Sun D; Jiao S
    BMC Cancer; 2021 Feb; 21(1):162. PubMed ID: 33588785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
    Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
    J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.
    Ronan K; Jordan E; Leonard C; McDermott R
    Ir J Med Sci; 2024 Jun; 193(3):1155-1161. PubMed ID: 37947995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
    Sonpavde G; Agarwal N; Pond GR; Nagy RJ; Nussenzveig RH; Hahn AW; Sartor O; Gourdin TS; Nandagopal L; Ledet EM; Naik G; Armstrong AJ; Wang J; Bilen MA; Gupta S; Grivas P; Pal SK; Lanman RB; Talasaz A; Lilly MB
    Cancer; 2019 May; 125(9):1459-1469. PubMed ID: 30620391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.
    Scott SN; Ostrovnaya I; Lin CM; Bouvier N; Bochner BH; Iyer G; Solit D; Berger MF; Lin O
    Cancer Cytopathol; 2017 Jun; 125(6):416-426. PubMed ID: 28339163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients.
    Palmieri M; Baldassarri M; Fava F; Fabbiani A; Gelli E; Tita R; Torre P; Petrioli R; Hadijstilianou T; Galimberti D; Cinotti E; Bengala C; Mandalà M; Piu P; Miano ST; Martellucci I; Vannini A; Pinto AM; Mencarelli MA; Marsili S; Renieri A; Frullanti E
    Cancer Med; 2020 Mar; 9(6):2052-2061. PubMed ID: 31991072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
    Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
    Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance.
    Barata PC; Koshkin VS; Funchain P; Sohal D; Pritchard A; Klek S; Adamowicz T; Gopalakrishnan D; Garcia J; Rini B; Grivas P
    Ann Oncol; 2017 Oct; 28(10):2458-2463. PubMed ID: 28945843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic and transcriptomic landscape of metastastic urothelial cancer.
    Loriot Y; Kamal M; Syx L; Nicolle R; Dupain C; Menssouri N; Duquesne I; Lavaud P; Nicotra C; Ngocamus M; Lacroix L; Tselikas L; Crehange G; Friboulet L; Castel-Ajgal Z; Neuzillet Y; Borcoman E; Beuzeboc P; Marret G; Gutman T; Wong J; Radvanyi F; Dureau S; Scoazec JY; Servant N; Allory Y; Besse B; Andre F; Le Tourneau C; Massard C; Bieche I
    Nat Commun; 2024 Oct; 15(1):8603. PubMed ID: 39366934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.
    Qin Y; Wang JR; Wang Y; Iyer P; Cote GJ; Busaidy NL; Dadu R; Zafereo M; Williams MD; Ferrarotto R; Gunn GB; Wei P; Patel K; Hofmann MC; Cabanillas ME
    Thyroid; 2021 Aug; 31(8):1235-1243. PubMed ID: 33599171
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study.
    Grivas P; Lalani AA; Pond GR; Nagy RJ; Faltas B; Agarwal N; Gupta SV; Drakaki A; Vaishampayan UN; Wang J; Barata PC; Gopalakrishnan D; Naik G; McGregor BA; Kiedrowski LA; Lanman RB; Sonpavde GP
    Eur Urol Oncol; 2020 Oct; 3(5):695-699. PubMed ID: 31412004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population.
    Souza VC; Monteiro FSM; Maluf FC; Werutsky G; Fabrício VC; Gidekel R; Gandur-Quiroga MN; Freitas MRP; Luz M; Campos-Gomez S; Junior JAR; Bastos DA; Sade JP; da Trindade KM; Mota ACA; Fernandes RC; Ruíz AOB; Pereira E Silva BD; de Oliveira FNG; Cutuli HJ; Nogueira L; Aceituno LFG; Fernandez M; Inman E; Caitano M; Herchenhorn D; Ardila-Salcedo J; Pacheco P; de Jesus RG; Gössling G; Soares A; Fay AP
    Clin Genitourin Cancer; 2024 Oct; 22(5):102174. PubMed ID: 39181783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
    Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
    Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.
    Ng CKY; Di Costanzo GG; Tosti N; Paradiso V; Coto-Llerena M; Roscigno G; Perrina V; Quintavalle C; Boldanova T; Wieland S; Marino-Marsilia G; Lanzafame M; Quagliata L; Condorelli G; Matter MS; Tortora R; Heim MH; Terracciano LM; Piscuoglio S
    Ann Oncol; 2018 May; 29(5):1286-1291. PubMed ID: 29509837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.
    Chung JH; Pavlick D; Hartmaier R; Schrock AB; Young L; Forcier B; Ye P; Levin MK; Goldberg M; Burris H; Gay LM; Hoffman AD; Stephens PJ; Frampton GM; Lipson DM; Nguyen DM; Ganesan S; Park BH; Vahdat LT; Leyland-Jones B; Mughal TI; Pusztai L; O'Shaughnessy J; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2017 Nov; 28(11):2866-2873. PubMed ID: 28945887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer.
    Chen C; Wang T; Yang M; Song J; Huang M; Bai Y; Su H
    Pathol Oncol Res; 2021; 27():1609879. PubMed ID: 34720757
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
    Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L
    Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.
    Tsui DWY; Cheng ML; Shady M; Yang JL; Stephens D; Won H; Srinivasan P; Huberman K; Meng F; Jing X; Patel J; Hasan M; Johnson I; Gedvilaite E; Houck-Loomis B; Socci ND; Selcuklu SD; Seshan VE; Zhang H; Chakravarty D; Zehir A; Benayed R; Arcila M; Ladanyi M; Funt SA; Feldman DR; Li BT; Razavi P; Rosenberg J; Bajorin D; Iyer G; Abida W; Scher HI; Rathkopf D; Viale A; Berger MF; Solit DB
    Genome Med; 2021 May; 13(1):96. PubMed ID: 34059130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.